The anticipated end of the due diligence period for the potential sale of MedAdvisor's Australian and New Zealand businesses is approaching, while the company manages challenges in its relationship with one of its largest shareholders. …
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Cartherics secures Chinese patent to boost immune cell function in solid tumours
August 27, 2025 - - Australian Biotech -
NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation
August 27, 2025 - - Australian Biotech -
Starpharma advances dendrimer platform with clinical, commercial, and strategic progress
August 27, 2025 - - Australian Biotech -
Biome achieves breakthrough year with first profit and rapid global expansion
August 27, 2025 - - Australian Biotech -
Neuren doubles profit as DAYBUE royalties and pipeline progress drive growth
August 27, 2025 - - Australian Biotech -
Sigma Healthcare delivers strong first-year results after Chemist Warehouse merger
August 27, 2025 - - Latest News -
Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push
August 27, 2025 - - Latest News